GCVRZ
Sanofi Contingent Value Rights
GCVRZ
GCVRZ
Delisted
GCVRZ was delisted on the 3rd of March, 2020.
103 hedge funds and large institutions have $140M invested in Sanofi Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 11 increasing their positions, 15 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
27% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 15
Holders
103
Holding in Top 10
3
Calls
$17.9M
Puts
–
Top Buyers
| 1 | +$2.04M | |
| 2 | +$1.33M | |
| 3 | +$816K | |
| 4 |
SCM
Stonehill Capital Management
New York
|
+$620K |
| 5 |
BCM
Brigade Capital Management
New York
|
+$428K |
Top Sellers
| 1 | -$280K | |
| 2 | -$170K | |
| 3 | -$144K | |
| 4 |
TL
TowerView LLC
New York
|
-$142K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$113K |